Adjuvant intravesical Mycobacterium bovis BCG is the treatment of choice for recurrent superficial bladder cancer. Fibronectin (FN) was previously demonstrated to be necessary for the retention of BCG within the bladder and for the expression of antitumor activity. Recent studies have demonstrated that BCG attach and are ingested by bladder epithelial cells, suggesting the existence of a second bacterial attachment mechanism. We report the characterization of the molecules involved in BCG attachment and internalization by the human bladder transitional cell carcinoma cell line T-24. Pretreatment of T-24 cells with monoclonal antibodies to either alpha 5 or beta 1 integrin subunits significantly inhibited both BCG attachment and ingestion. Exogenous FN was observed to enhance both attachment and ingestion of BCG, and anti-FN was observed to inhibit both phenomena. Latex beads precoated with either FN or laminin (LN) but not BSA were ingested by T-24 cells, but only FN-coated beads inhibited BCG attachment and ingestion. Pretreatment of BCG with FN augmented both attachment and ingestion. 
Introduction
In 1976, Morales and associates first reported the efficacy of adjuvant intravesical BCG for superficial bladder cancer ( 1). Since the initial report, prospective randomized studies have demonstrated BCG to be superior to surgery alone (2), adjuvant thiotepa (3) , and adjuvant Adriamycin (4, 5) . Although the efficacy of BCG is clearly established, the mechanisms by which BCG mediates antitumor activity are not clearly understood.
Previous studies have shown that BCG attachment to fibronectin (FN)' in the bladder lumen is required for the development ofan antitumor response (6) . Inhibition ofFN-mediated BCG attachment was shown to inhibit immunization, the expression of delayed type hypersensitivity and antitumor activity (6) . Further studies showed that BCG-mediated antitumor activity was dependent on T lymphocytes (7) . These studies led to the hypothesis that BCG-induced antitumor activity is comprised of a series of events that begin with attachment and progress through immune activation and culminate in tumor destruction.
Recent studies demonstrated that BCG attach to and are ingested by bladder epithelial cells (8) . Although the role of cellular attachment and ingestion by epithelial cells in BCGmediated antitumor activity has not been clearly established, this observation suggests that BCG interaction with tumor cells may be associated with immune modulation. Therefore, we initiated studies to better define the interaction of transitional epithelial carcinoma cells with BCG.
The mechanisms of attachment and internalization of microorganisms by cultured nonphagocytic cells has been extensively investigated (9) (10) (11) (12) . Recently, Isberg and Leong reported that attachment and ingestion of Yersinia pseudotuberculosis by mammalian cells was mediated by integrin receptors ( 13). This resulted from the direct interaction of a bacterial protein, invasin, with several ,B, integrins. Subsequent reports have confirmed the observation and extended it to other bacteria (14) .
The objective ofthis study was to characterize and evaluate the components involved in BCG attachment and internalization by the bladder tumor cell line T-24. We demonstrate that BCG attachment and ingestion are mediated at least in part by the a5 pi integrin receptor, and that both processes can be modulated by FN.
Methods
Bladder tumor cells. The human transitional cell carcinoma cell line T-24 was obtained from American Type Culture Collection (Rockville, MD). The cells were cultured in medium containing Earle's MEM supplemented with 50 U/ml penicillin, 50 U/ml streptomycin, 1% L-glutamine, and 10% FCS. All tissue culture media and supplements were purchased from Washington University Cancer Center (St. Louis, MO). Tests for mycoplasma were negative.
BCG. Pasteur strain (Armand Frappier, Quebec, Canada) at 120 mg/vial was used. The vaccine was a lyophilized preparation contain-ing 107 CFUI/mg dry wt. A 120-mg ampule of BCG was suspended in 10 ml prewarmed RPMI 1640, and particles representing one or a few bacteria were isolated by a modification of the method reported by Rook and associates ( 15 ). The suspension was centrifuged at 3,000 g for 10 min at 24°C. After the medium was removed, BCG were resuspended in 10 ml RPMI 1640 and centrifuged at 250 g for 3 min at 24°C to eliminate large clumps of bacteria. The top 5 ml of the suspension was removed and used in the attachment and ingestion assay. The number of organisms was determined by measuring the optical density at wave length of 595 nm and comparing it to a previously established standard curve quantitating CFU from optical densities using the particle isolation technique described above.
Antibodies. Rabbit polyclonal anti-BCG and anti-FN antibodies were purchased from Dako Corp. (Santa Barbara, CA). Rat monoclonal antibodies, B l E5 directed against the a5 integrin subunit and AIIB2 directed against the fl, integrin subunit were provided by Dr. Caroline Damsky, University of California (San Francisco, CA) (16 BCG ingestion assay. T-24 cells were removed from tissue culture flasks using 10 mM EDTA in PBS, pH 7.2. 105 cells in Earle's MEM with the same supplements described above were plated into each well ofchamber slides (Lab-Tek 8; Miles Laboratories, Naperville, IL). The cultures were incubated at 37°C in 5% CO2 overnight. Alternatively, T-24 cells were plated in Lab-Tek chambers precoated overnight with FN, LN, or VN as previously described (22) . Cells were allowed to attach for 2 h. Attached cells were washed twice with prewarmed PBS, and I0 5 CFU BCG were added into each chamber containing adherent T-24 cells. The cultures were incubated at 37°C in 5% CO2 for 3 h to allow BCG internalization.
Attachment and ingestion were assessed by a modification of the double immunofluorescence assay described by Portnoy et al. (23) . After washing, 10% horse serum in PBS was added for 30 min to block nonspecific antibody binding. Blocking was followed by the addition of a 1:100 dilution of polyclonal rabbit anti-BCG antibody for 30 min. After washing, 1:200 dilution ofFITC-conjugated goat anti-rabbit IgG was added for 30 min to stain extracellular BCG. After washing, methanol was added for 5 min to permeablize the T-24 cells. Subsequently, both extracellular and intracellular BCG were stained with RITC by adding anti-BCG antibody followed by 1:200 dilution of RITC-conjugated goat anti-rabbit IgG as described for the FITC antibody. After washing, slides were mounted in a solution containing 50% glycerol and 0.1% p-phenylenediamine (Sigma Chemical Company, St. Louis, MO) in PBS. All staining procedures were carried out at room temperature, and all antibodies were diluted with 10% horse serum in PBS. A representative photograph demonstrating attached (stained with both FITC and RITC) and ingested (stained with RITC only) bacteria is provided in Fig. 1 Electron microscopy. The ingestion assay was performed as described above. Electron microscopy was performed as previously described (8) . Briefly, cells were fixed in 1% glutaraldehyde in HBSS and h. (Fig. 3 A) . An even greater decrease in BCG ingestion was observed for anti-d, and
anti-a5 (Fig. 3 B) . (Fig. 4) . The highest concentration of FN ( 100 ,Ag/well) increased BCG attachment by 91.8% (P < 0.01 ) and ingestion by 82.3% (P < 0.001 ). LN had no effect on either attachment or ingestion. T-24 attachment and spreading was indistinguishable on LN-and FN-coated surfaces. However, Fig. 7) (summarized in Fig. 3 ) (summarized in Fig. 5 ) (summarized in Fig. 10 BCG augmented attachment and ingestion by T-24 cells ( Fig. 7 and (Fig. 8) .
Competition experiments were performed in which either LN-or FN-coated beads were coincubated with BCG in the ingestion assay. FN-coated beads but not LN-coated beads inhibited BCG attachment and ingestion, suggesting competition for the same T-24 receptor (Fig. 9) .
Effect ofantibodies to BCG surface components on attachment and ingestion. To further explore the necessity for FN binding by BCG in attachment and ingestion by T-24, we evaluated the BCG surface structures required for recognition. Poly- clonal anti-BCG completely inhibited both attachment and ingestion, demonstrating that a specific interaction was required (data not shown). Importantly, an mAb that recognizes the BCG 55-kD FN receptor (anti-p55) and prevents BCG attachment to FN (Ratliff, T. L., R. J. McCarthy, and E. J. Brown, manuscript submitted for publication) also inhibited BCG attachment and ingestion (Fig. 10 ). These data demonstrate that this bacterial receptor is necessary for BCG attachment to T-24 cells, and are consistent with the hypothesis that FN mediates binding of BCG to this transitional epithelial cell line.
Discussion
The binding of BCG to FN is a necessary step in the development ofan antitumor response after the intravesical instillation of BCG for bladder cancer (6 (31, 32) ; however, these receptors are not expressed on T-24 cells (unpublished observation). The modulation of unknown phagocytic receptors for BCG cannot be definitively excluded, although all our data are supportive of a direct opsonic role for FN.
Previous studies have evaluated the effect of FN on bacterial attachment and phagocytosis by macrophages, neutrophils, and endothelial cells (33) (34) (35) . These studies have uniformly shown FN to mediate attachment but not to initiate ingestion. van In a review of bacterial attachment mechanisms, Isberg (13) suggested that the primary function of bacterial attachment to extracellular matrix proteins was colonization, while the initiation of ingestion required direct attachment of bacteria to integrin receptors. This hypothesis was supported by studies on Y. pseudotuberculosis invasion of mammalian epithelial cell lines ( 14) . In these studies, the protein invasin, which is known to be sufficient for inducing attachment and ingestion by traditionally nonphagocytic cells, was shown to attach to A, integrin receptors. Similar results were reported for Bordetella pertussis ( 14 (6) , but it also plays a critical role in uptake by the epithelial tumors themselves. Presumably, uptake is followed by lysosomal degradation and antigen presentation to the immune system. If this hypothesis is correct, the mycobacterial FN receptor, apparently well conserved through the genus, may play a critical role in initiation of the antitumor response.
